Packaged Foods
Compare Stocks
5 / 10Stock Comparison
MKC vs MDLZ vs SJM vs CPB vs GIS
Revenue, margins, valuation, and 5-year total return — side by side.
Food Confectioners
Packaged Foods
Packaged Foods
Packaged Foods
MKC vs MDLZ vs SJM vs CPB vs GIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Food Confectioners | Packaged Foods | Packaged Foods | Packaged Foods |
| Market Cap | $12.14B | $78.70B | $10.58B | $6.34B | $19.05B |
| Revenue (TTM) | $6.84B | $39.30B | $8.93B | $10.04B | $18.37B |
| Net Income (TTM) | $789M | $2.61B | $-1.26B | $550M | $2.21B |
| Gross Margin | 37.9% | 28.8% | 33.6% | 29.3% | 33.0% |
| Operating Margin | 15.7% | 9.4% | -8.0% | 12.1% | 19.1% |
| Forward P/E | 15.5x | 20.1x | 11.0x | 9.7x | 10.4x |
| Total Debt | $4.00B | $22.40B | $7.76B | $7.21B | $15.30B |
| Cash & Equiv. | $96M | $2.13B | $70M | $132M | $364M |
MKC vs MDLZ vs SJM vs CPB vs GIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| McCormick & Company… (MKC) | 100 | 54.7 | -45.3% |
| Mondelez Internatio… (MDLZ) | 100 | 117.6 | +17.6% |
| The J. M. Smucker C… (SJM) | 100 | 87.3 | -12.7% |
| Campbell Soup Compa… (CPB) | 100 | 41.7 | -58.3% |
| General Mills, Inc. (GIS) | 100 | 56.6 | -43.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MKC vs MDLZ vs SJM vs CPB vs GIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, MKC doesn't own a clear edge in any measured category.
MDLZ ranks third and is worth considering specifically for long-term compounding.
- 68.4% 10Y total return vs SJM's 5.6%
- -5.8% vs CPB's -35.4%
SJM is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 15 yrs, beta 0.04, yield 4.3%
- Lower volatility, beta 0.04, current ratio 0.81x
- Beta 0.04, yield 4.3%, current ratio 0.81x
- 6.7% revenue growth vs GIS's -1.9%
CPB is the clearest fit if your priority is growth exposure.
- Rev growth 6.4%, EPS growth 6.3%, 3Y rev CAGR 6.2%
- 7.2% yield, 1-year raise streak, vs MKC's 3.7%
GIS carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 3.64 vs MKC's 14.63
- Lower P/E (10.4x vs 11.0x)
- 12.1% margin vs SJM's -14.1%
- 6.8% ROA vs SJM's -7.7%, ROIC 10.6% vs -3.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.7% revenue growth vs GIS's -1.9% | |
| Value | Lower P/E (10.4x vs 11.0x) | |
| Quality / Margins | 12.1% margin vs SJM's -14.1% | |
| Stability / Safety | Beta 0.04 vs MDLZ's 0.06 | |
| Dividends | 7.2% yield, 1-year raise streak, vs MKC's 3.7% | |
| Momentum (1Y) | -5.8% vs CPB's -35.4% | |
| Efficiency (ROA) | 6.8% ROA vs SJM's -7.7%, ROIC 10.6% vs -3.4% |
MKC vs MDLZ vs SJM vs CPB vs GIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MKC vs MDLZ vs SJM vs CPB vs GIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CPB leads in 1 of 6 categories
GIS leads 1 • MDLZ leads 1 • MKC leads 0 • SJM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MKC and MDLZ and GIS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MDLZ is the larger business by revenue, generating $39.3B annually — 5.7x MKC's $6.8B. GIS is the more profitable business, keeping 12.1% of every revenue dollar as net income compared to SJM's -14.1%. On growth, MDLZ holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $6.8B | $39.3B | $8.9B | $10.0B | $18.4B |
| EBITDAEarnings before interest/tax | $1.3B | $4.9B | -$595M | $1.6B | $3.9B |
| Net IncomeAfter-tax profit | $789M | $2.6B | -$1.3B | $550M | $2.2B |
| Free Cash FlowCash after capex | $879M | $2.6B | $971M | $919M | $1.7B |
| Gross MarginGross profit ÷ Revenue | +37.9% | +28.8% | +33.6% | +29.3% | +33.0% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +9.4% | -8.0% | +12.1% | +19.1% |
| Net MarginNet income ÷ Revenue | +11.5% | +6.6% | -14.1% | +5.5% | +12.1% |
| FCF MarginFCF ÷ Revenue | +12.8% | +6.6% | +10.9% | +9.2% | +9.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +8.2% | +7.0% | -4.5% | -8.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.0% | +38.7% | -9.3% | -17.2% | -50.0% |
Valuation Metrics
CPB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 8.7x trailing earnings, GIS trades at a 73% valuation discount to MDLZ's 32.4x P/E. Adjusting for growth (PEG ratio), GIS offers better value at 3.04x vs MKC's 15.47x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12.1B | $78.7B | $10.6B | $6.3B | $19.1B |
| Enterprise ValueMkt cap + debt − cash | $16.0B | $99.0B | $18.3B | $13.4B | $34.0B |
| Trailing P/EPrice ÷ TTM EPS | 16.35x | 32.44x | -8.59x | 10.57x | 8.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.46x | 20.06x | 11.01x | 9.74x | 10.43x |
| PEG RatioP/E ÷ EPS growth rate | 15.47x | — | — | — | 3.04x |
| EV / EBITDAEnterprise value multiple | 12.12x | 19.88x | — | 7.51x | 8.84x |
| Price / SalesMarket cap ÷ Revenue | 1.78x | 2.04x | 1.21x | 0.62x | 0.98x |
| Price / BookPrice ÷ Book value/share | 2.24x | 3.07x | 1.74x | 1.63x | 2.16x |
| Price / FCFMarket cap ÷ FCF | 16.40x | 24.33x | 12.96x | 8.99x | 8.31x |
Profitability & Efficiency
GIS leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
GIS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-24 for SJM. MKC carries lower financial leverage with a 0.69x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPB's 1.85x. On the Piotroski fundamental quality scale (0–9), CPB scores 7/9 vs GIS's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +13.7% | +10.0% | -24.0% | +14.0% | +23.7% |
| ROA (TTM)Return on assets | +6.0% | +3.7% | -7.7% | +3.7% | +6.8% |
| ROICReturn on invested capital | +8.5% | +6.0% | -3.4% | +9.1% | +10.6% |
| ROCEReturn on capital employed | +10.7% | +7.3% | -4.3% | +11.4% | +13.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.69x | 0.87x | 1.28x | 1.85x | 1.66x |
| Net DebtTotal debt minus cash | $3.9B | $20.3B | $7.7B | $7.1B | $14.9B |
| Cash & Equiv.Liquid assets | $96M | $2.1B | $70M | $132M | $364M |
| Total DebtShort + long-term debt | $4.0B | $22.4B | $7.8B | $7.2B | $15.3B |
| Interest CoverageEBIT ÷ Interest expense | 5.65x | 10.01x | -1.88x | 3.14x | 5.01x |
Total Returns (Dividends Reinvested)
MDLZ leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MDLZ five years ago would be worth $11,260 today (with dividends reinvested), compared to $5,806 for CPB. Over the past 12 months, MDLZ leads with a -5.8% total return vs CPB's -35.4%. The 3-year compound annual growth rate (CAGR) favors MDLZ at -5.1% vs CPB's -22.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -28.1% | +15.2% | +4.0% | -20.5% | -19.2% |
| 1-Year ReturnPast 12 months | -33.6% | -5.8% | -7.5% | -35.4% | -29.9% |
| 3-Year ReturnCumulative with dividends | -39.8% | -14.5% | -28.5% | -52.6% | -52.3% |
| 5-Year ReturnCumulative with dividends | -37.2% | +12.6% | -12.0% | -41.9% | -25.3% |
| 10-Year ReturnCumulative with dividends | +26.9% | +68.4% | +5.6% | -44.9% | -9.2% |
| CAGR (3Y)Annualised 3-year return | -15.6% | -5.1% | -10.6% | -22.0% | -21.8% |
Risk & Volatility
Evenly matched — MDLZ and GIS each lead in 1 of 2 comparable metrics.
Risk & Volatility
GIS is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than MDLZ's 0.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MDLZ currently trades 86.2% from its 52-week high vs CPB's 58.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.03x | 0.06x | 0.04x | -0.02x | -0.04x |
| 52-Week HighHighest price in past year | $78.16 | $71.15 | $119.39 | $36.16 | $55.35 |
| 52-Week LowLowest price in past year | $47.31 | $51.20 | $88.25 | $19.76 | $33.58 |
| % of 52W HighCurrent price vs 52-week peak | +61.3% | +86.2% | +83.3% | +58.8% | +64.5% |
| RSI (14)Momentum oscillator 0–100 | 33.8 | 68.7 | 50.1 | 46.7 | 42.2 |
| Avg Volume (50D)Average daily shares traded | 4.0M | 9.0M | 2.1M | 9.1M | 8.7M |
Analyst Outlook
Evenly matched — MKC and CPB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MKC as "Hold", MDLZ as "Buy", SJM as "Hold", CPB as "Hold", GIS as "Hold". Consensus price targets imply 52.8% upside for MKC (target: $73) vs 9.3% for MDLZ (target: $67). For income investors, CPB offers the higher dividend yield at 7.20% vs MDLZ's 3.13%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $73.20 | $67.00 | $113.38 | $25.83 | $46.58 |
| # AnalystsCovering analysts | 30 | 41 | 29 | 29 | 34 |
| Dividend YieldAnnual dividend ÷ price | +3.7% | +3.1% | +4.3% | +7.2% | +6.7% |
| Dividend StreakConsecutive years of raises | 27 | 12 | 15 | 1 | 5 |
| Dividend / ShareAnnual DPS | $1.79 | $1.92 | $4.28 | $1.53 | $2.40 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +3.0% | +0.0% | +1.0% | +6.3% |
CPB leads in 1 of 6 categories (Valuation Metrics). GIS leads in 1 (Profitability & Efficiency). 3 tied.
MKC vs MDLZ vs SJM vs CPB vs GIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MKC or MDLZ or SJM or CPB or GIS a better buy right now?
For growth investors, The J.
M. Smucker Company (SJM) is the stronger pick with 6. 7% revenue growth year-over-year, versus -1. 9% for General Mills, Inc. (GIS). General Mills, Inc. (GIS) offers the better valuation at 8. 7x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate Mondelez International, Inc. (MDLZ) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MKC or MDLZ or SJM or CPB or GIS?
On trailing P/E, General Mills, Inc.
(GIS) is the cheapest at 8. 7x versus Mondelez International, Inc. at 32. 4x. On forward P/E, Campbell Soup Company is actually cheaper at 9. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: General Mills, Inc. wins at 3. 64x versus McCormick & Company, Incorporated's 14. 63x.
03Which is the better long-term investment — MKC or MDLZ or SJM or CPB or GIS?
Over the past 5 years, Mondelez International, Inc.
(MDLZ) delivered a total return of +12. 6%, compared to -41. 9% for Campbell Soup Company (CPB). Over 10 years, the gap is even starker: MDLZ returned +68. 4% versus CPB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MKC or MDLZ or SJM or CPB or GIS?
By beta (market sensitivity over 5 years), General Mills, Inc.
(GIS) is the lower-risk stock at -0. 04β versus Mondelez International, Inc. 's 0. 06β — meaning MDLZ is approximately -267% more volatile than GIS relative to the S&P 500. On balance sheet safety, McCormick & Company, Incorporated (MKC) carries a lower debt/equity ratio of 69% versus 185% for Campbell Soup Company — giving it more financial flexibility in a downturn.
05Which is growing faster — MKC or MDLZ or SJM or CPB or GIS?
By revenue growth (latest reported year), The J.
M. Smucker Company (SJM) is pulling ahead at 6. 7% versus -1. 9% for General Mills, Inc. (GIS). On earnings-per-share growth, the picture is similar: Campbell Soup Company grew EPS 6. 3% year-over-year, compared to -262. 3% for The J. M. Smucker Company. Over a 3-year CAGR, MDLZ leads at 7. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MKC or MDLZ or SJM or CPB or GIS?
General Mills, Inc.
(GIS) is the more profitable company, earning 11. 8% net margin versus -14. 1% for The J. M. Smucker Company — meaning it keeps 11. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GIS leads at 17. 0% versus -7. 7% for SJM. At the gross margin level — before operating expenses — SJM leads at 38. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MKC or MDLZ or SJM or CPB or GIS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, General Mills, Inc. (GIS) is the more undervalued stock at a PEG of 3. 64x versus McCormick & Company, Incorporated's 14. 63x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Campbell Soup Company (CPB) trades at 9. 7x forward P/E versus 20. 1x for Mondelez International, Inc. — 10. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MKC: 52. 8% to $73. 20.
08Which pays a better dividend — MKC or MDLZ or SJM or CPB or GIS?
All stocks in this comparison pay dividends.
Campbell Soup Company (CPB) offers the highest yield at 7. 2%, versus 3. 1% for Mondelez International, Inc. (MDLZ).
09Is MKC or MDLZ or SJM or CPB or GIS better for a retirement portfolio?
For long-horizon retirement investors, McCormick & Company, Incorporated (MKC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
03), 3. 7% yield). Both have compounded well over 10 years (MKC: +26. 9%, SJM: +5. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MKC and MDLZ and SJM and CPB and GIS?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MKC is a mid-cap deep-value stock; MDLZ is a mid-cap income-oriented stock; SJM is a mid-cap income-oriented stock; CPB is a small-cap deep-value stock; GIS is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.